You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Deutsche Telekom AG (DTEGY) - free report >>
Cyngn Inc. (CYN) - free report >>
Oncolytics Biotech Inc. (ONCY) - free report >>
Image: Bigstock
New Strong Buy Stocks for January 18th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Deutsche Telekom AG (DTEGY - Free Report) : This integrated telecommunication services company has seen the Zacks Consensus Estimate for its current year earnings increasing 20.4% over the last 60 days.
Deutsche Telekom AG Price and Consensus
Deutsche Telekom AG price-consensus-chart | Deutsche Telekom AG Quote
Cyngn Inc. (CYN - Free Report) : This autonomous vehicle technology company has seen the Zacks Consensus Estimate for its current year earnings increasing 22.2% over the last 60 days.
Cyngn Inc. Price and Consensus
Cyngn Inc. price-consensus-chart | Cyngn Inc. Quote
Okta, Inc. (OKTA - Free Report) : This identity solutions company has seen the Zacks Consensus Estimate for its current year earnings increasing 62% over the last 60 days.
Okta, Inc. Price and Consensus
Okta, Inc. price-consensus-chart | Okta, Inc. Quote
Werewolf Therapeutics, Inc. (HOWL - Free Report) : This cancer focused biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 6% over the last 60 days.
Werewolf Therapeutics, Inc. Price and Consensus
Werewolf Therapeutics, Inc. price-consensus-chart | Werewolf Therapeutics, Inc. Quote
Oncolytics Biotech Inc. (ONCY - Free Report) : This development-stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 9.4% over the last 60 days.
Oncolytics Biotech Inc. Price and Consensus
Oncolytics Biotech Inc. price-consensus-chart | Oncolytics Biotech Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.